Andorra vs Bosnia and Herzegovina: New cases tested for RR-/MDR-TB
Andorra
75.0%
in 2023
Bosnia and Herzegovina
74.0%
in 2024
Andorra rank
134th
Bosnia and Herzegovina rank
135th
New cases tested for RR-/MDR-TB over time
- Andorra
- Bosnia and Herzegovina
How they compare
Andorra currently reports 75.0% against 74.0% in Bosnia and Herzegovina, a difference of 1.0%.
The two have swapped places 6 times across 19 shared years of data; in 2005 it was Bosnia and Herzegovina ahead.
Andorra ranks 134th and Bosnia and Herzegovina ranks 135th of 192 countries.
Bosnia and Herzegovina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Bosnia and Herzegovina | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.4% | 100.0% | 6.6% | Bosnia and Herzegovina |
| 2010s | 90.0% | 97.8% | 7.8% | Bosnia and Herzegovina |
| 2020s | 93.8% | 97.8% | 4.0% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Andorra or Bosnia and Herzegovina?
- Andorra, at 75.0% against 74.0% in Bosnia and Herzegovina as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Andorra and Bosnia and Herzegovina?
- 1.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Bosnia and Herzegovina?
- 19 years are reported by both, from 2005 to 2023.
- How do Andorra and Bosnia and Herzegovina rank globally for new cases tested for rr-/mdr-tb?
- Andorra ranks 134th and Bosnia and Herzegovina ranks 135th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.